Goldman Sachs reduces share in Orphazyme and drops below 5 percent boundary
![Photo: DAVID GRAY/REUTERS / X00503](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13080650.ece/ALTERNATES/schema-16_9/doc7gcmakt3vqasxyke7dd.jpg)
US company Goldman Sachs has divested shares in Danish biotech firm Orphazyme, and as of June 17, owns less than 5 percent of the company, Orphazyme reported on Wednesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.